|
|
|
| Webinar - Driving CDMO Efficiency: The Power of Flexible Platforms and Digital Data Access | We’ll demonstrate how KBI Biopharma’s mammalian (SUREtechnology) and microbial (PUREplatform) expression platforms, combined with industry-leading analytical capabilities, accelerate the development and manufacturing of mAbs, multispecific Abs, ADCs, fusion proteins, and other recombinant therapeutic proteins. We’ll also showcase PROGRAMview, our cutting-edge digital data access tool, highlighting its role in enhancing data access and collaboration during process development. Register here. |
|
|
|
|
By Louis Garguilo, Chief Editor, Outsourced Pharma | An experienced healthcare investor/consultant, and former biotech CEO, puts on his thinking cap to provide readers some intriguing insights into your development and manufacturing outsourcing, and overall business model for new drugs and therapies. |
|
|
|
By Kara Quinn and Ewelina Flamm | In part 1 of this 2-part series, the authors discussed the case for outsourcing of custom media/buffer formulations. In this article, they discuss key considerations in the case for vertical integration, or insourcing. |
|
|
|
|
|
|
|
|
|
|
|
|
| Webinar: Accelerating Drug Development for Biologics: Flexible and Fast DNA-to-IND Programs | Join us on July 8th with Lonza to explore innovative strategies and good practices to accelerate the pathway to clinic, increase specific productivity, and enhance product yield. This session will delve into comprehensive and integrated drug substance/drug product DNA-to-IND programs designed to expedite development across various modalities, including monoclonal antibodies, bispecific antibodies, Fabs, Fc-fusions and non-Fc recombinant proteins. Click here to learn more. |
|
|
|
Analytical Assay Development And Qualification | JOINN Biologics | By providing sensitive and accurate analytical data, analytics can help upstream development by performing spent media analysis or downstream purification by analyzing protein products. |
|
|
Be A Gain Changer, 2x Throughput, Only With Supor Prime | Cytiva | Engineered to deliver the high throughput capacity of high-value drug products, Cytiva Supor™ Prime filters minimize product loss and waste, guaranteeing optimal yield. Watch to learn more about these innovative filters. |
|
|
Scale Your Vaccine With Path-To-PAD | Resilience US, Inc. | Our Vaccine Path-To-PAD program provides a clear and easy path to maximize yields at the beginning of development, with deep expertise in vaccines, robust expression platforms, and high-quality Vero and Quail cell lines. |
|
|
|
OUTSOURCED PHARMA CAPACITY UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
Connect With Outsourced Pharma: |
|
|
|